Shanliang Zheng

Shanliang Zheng

Auto-generated profile, based on publicly available information

Shanliang Zheng

School of Life Science and Technology, Harbin Institute of Technology, Harbin, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2024 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
HLHao Liu
Hao Liu
SZShanliang Zheng
Shanliang Zheng
GHGuixue Hou
Guixue Hou
JDJunren Dai
Junren Dai
YZYanan Zhao
Yanan Zhao
YHYing Hu
Ying Hu

15 November 2022 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
SZShanliang Zheng
Shanliang Zheng
XWXingwen Wang
Xingwen Wang
HLHao Liu
Hao Liu
DZDong Zhao
Dong Zhao
QLQingyu Lin
Qingyu Lin
YHYing Hu
Ying Hu
Unfolded protein response (UPR) signaling is activated under endoplasmic reticulum (ER) stress, an emerging cancer hallmark, leading to either adaptive survival or cell death, while the mechanisms underlying adaptation-death switch remain poorly understood. Here, we examined whether oncogene iASPP regulates the switch and how the mechanisms can be used in colon cancer treatment. iASPP is downregulated when cells undergo transition from adaptation to death during therapy-induced ER stress. Blocking iASPP’s downregulation attenuates stress-induced cell death. Mechanistically, Hu-antigen R (HuR)-mediated stabilization of iASPP mRNA and subsequent iASPP protein production is significantly impaired with prolonged ER stress, which facilitates the degradation of GRP78, a key regulator of the UPR, in the cytosol. Because iASPP competes with GRP78 in binding the ER-resident E3 ligase RNF185, and tips the balance in favor of cell death. Positive correlation between the levels of HuR, iASPP, and GRP78 are detectable in colon cancer tissues in vivo. Genetic inhibition of iASPP/GRP78 or chemical inhibition of HuR not only inhibits tumor growth, but also sensitizes colon cancer cells’ responses to BRAF inhibitor-induced ER stress and cell death. This study provides mechanistic insights into the switch between adaptation and death during ER stress, and also identifies a potential strategy to improve BRAF-inhibitor efficiency in colon cancers.